Retrophin Names Dr. Horacio Plotkin CMO

New York-based Retrophin, a pharmaceutical company, has named Horacio Plotkin, MD, its chief medical officer, effective May 13, according to a Fort Mills Times report.

Advertisement

Most recently, Dr. Plotkin served as executive medical director of clinical research for Alexion Pharmaceuticals. He currently serves as adjunct associate professor of pediatrics and orthopedic surgery at the University of Nebraska Medical Center in Omaha.  

More Articles on Executive Appointments:

10 Spine Device Company Executive Moves
Sonoma Orthopedic Products Hires 3 New Executives
AAOS Names Eight New Executives

Advertisement

Next Up in Practice Management

  • Philadelphia-based Rothman Orthopaedics saw many accomplishments in 2025 including new leadership and partnerships. 11 updates: 1. Rothman Orthopaedics has partnered with the…

  • Bettendorf, Iowa-based ORA Orthopedics and UnityPoint Health – Trinity hospitals are partnering, effective Dec. 18. ORA Orthopedics and UnityPoint Health…

Advertisement

Comments are closed.